| Name | Title | Contact Details |
|---|
At ReSound, people with hearing loss are at the heart of everything we do. We think big and challenge the norm, because we believe Smart Hearing has the power to transform lives. Our award-winning Smart Hearing aids help people feel more involved, connected and in control. They deliver the best sound quality and optimal design. Smart Hearing aids also work like wireless stereo headphones, streaming sound directly to the hearing aids from devices like an iPhone® or a TV. An accompanying app gives full control and the ability to personalize each hearing experience. ReSound hearing aids are exclusively available through hearing care professionals, who adjust them to each individual`s specific hearing loss. With research teams in USA and Holland, we are headquartered in Denmark. ReSound is part of the GN Group, pioneering great sound from world leading ReSound hearing aids to Jabra office headsets and sports headphones. Founded in 1869, building on a strong legacy of innovative audio and communications solutuions, and listed on NSDAQ OMX Copenhagen, GN makes life sound better.
Intelligent Implants is a medical device company operating at the intersection of digital medicine and orthopedics. We develop innovative electrotherapeutic orthopedic devices to address significant unmet clinical needs. The company`s SmartFuse® platform is a wirelessly enabled, active implant technology that uses an array of electrodes to stimulate, control, and monitor bone growth. Our mission is to leverage SmartFuse to develop a pipeline of smart orthopedic implants that can reduce healing times, engage patients & surgeons, enable digital surgery/robotics and ultimately improve outcomes for millions of patients.
Hygia Health Services is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SurgiTel is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
VisCardia Inc is a privately held medical device company in Portland Oregon developing a novel chronic heart failure therapy. Our proprietary implantable system uses the patient’s own thoracic musculature to improve cardiac filling and output.